Evidence map›Paper›PMID 24813610›Full record

ArticleCell2014

A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response.

Roman Alpatov, Bluma J Lesch, Mika Nakamoto-Kinoshita, Andres Blanco, Shuzhen Chen, Alexandra Stützer, Karim J Armache, Matthew D Simon, Chao Xu, Muzaffar Ali and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 181 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The enigma of nuclear FMRP: facts and myths.Frontiers in cell and developmental biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Genome-Wide Identification, Characterization and Expression Analysis of theInternational journal of molecular sciences · 2023
    Article
  17. The TUDOR domain of SMN is an H3K79Life science alliance · 2023
    Article
  18. Narrative Review: Update on the Molecular Diagnosis of Fragile X Syndrome.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Roman AlpatovDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Bluma J LeschHoward Hughes Medical Institute, Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Mika Nakamoto-KinoshitaDepartments of Human Genetics, Biochemistry, and Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Andres BlancoDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Shuzhen ChenDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Alexandra StützerLaboratory of Chromatin Biochemistry, Max Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany.
Karim J ArmacheMassachusetts General Hospital, Department of Molecular Biology and Department of Genetics, Harvard Medical School, Boston, MA 02114, USA.
Matthew D SimonMassachusetts General Hospital, Department of Molecular Biology and Department of Genetics, Harvard Medical School, Boston, MA 02114, USA.
Chao XuStructural Genomics Consortium and Department of Physiology, University of Toronto, Toronto ON M5G 1L7, Canada.
Muzaffar AliDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Jernej MurnDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Sladjana PrisicDivision of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Tatiana G KutateladzeDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Christopher R VakocCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Jinrong MinStructural Genomics Consortium and Department of Physiology, University of Toronto, Toronto ON M5G 1L7, Canada.
Robert E KingstonMassachusetts General Hospital, Department of Molecular Biology and Department of Genetics, Harvard Medical School, Boston, MA 02114, USA.
Wolfgang FischleLaboratory of Chromatin Biochemistry, Max Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany.
Stephen T WarrenDepartments of Human Genetics, Biochemistry, and Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
David C PageHoward Hughes Medical Institute, Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Yang ShiDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: yang_shi@hms.harvard.edu.
Boston Children's Hospital · USHarvard University · USEmory University · USMassachusetts General Hospital · USMax Planck Institute for Biophysical Chemistry · DEUniversity of Colorado Denver · USWhitehead Institute for Biomedical Research · USCold Spring Harbor Laboratory · USStructural Genomics Consortium · CAUniversity of Toronto · CA

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 1988 to 2013
$29.4M
SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
Training in the Molecular Biology of Neurodegeneration and Alzheimer's DiseaseT32AG000222 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Bruce A YANKNER · 1992 to 2026
$18.5M
Maintenance of Gene ExpressionR01GM043901 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI KINGSTON, ROBERT · 1991 to 2018
$10.7M
Novel epigenetic mechanisms in neuronal development and cognitive functionR01MH096066 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI ARLOTTA, PAOLA, POMEROY, SCOTT LOREN · 2012 to 2022
$6.1M
Histone Demethylases and Regulation of Chromatin and Transcription in EukaryotesR01CA118487 · NCI · HARVARD MEDICAL SCHOOL · PI SHI, YANG · 2006 to 2017
$3.6M
Schizophrenia susceptibility by copy number variation in the AshkenazimR01MH080129 · NIMH · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 2007 to 2011
$3.4M
MOLECULAR CLONING OF THE FRAGILE X SITER01HD020521 · NICHD · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 1986 to 2011
$2.8M
Tet-mediated Epigenetic Modulation in AutismR01MH102690 · NIMH · EMORY UNIVERSITY · PI JIN, PENG, WARREN, STEPHEN T. · 2014 to 2017
$2.6M
MOLECULAR CLONING OF THE FRAGILE X SITER37HD020521 · NICHD · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 1996 to 2005
$1.7M
Molecular analysis of methylated p53R01GM101664 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2013 to 2016
$1.7M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA014051NCI NIH HHS R01 CA118487NIA NIH HHS AG00222-7NIA NIH HHS T32 AG000222NICHD NIH HHS F32 HD075591NICHD NIH HHS HD020521NICHD NIH HHS HD024064NICHD NIH HHS HD075591NICHD NIH HHS P30 HD018655NICHD NIH HHS P30 HD024064NICHD NIH HHS R01 HD020521NICHD NIH HHS R37 HD020521NIGMS NIH HHS R01 GM043901NIGMS NIH HHS R01 GM101664NIMH NIH HHS MH096066NIMH NIH HHS R01 MH080129NIMH NIH HHS R01 MH096066NIMH NIH HHS R01 MH102690PHS HHS NCI118487Wellcome Trust 092809
6 · The paper itself

Abstract

Fragile X syndrome, a common form of inherited intellectual disability, is caused by loss of the fragile X mental retardation protein FMRP. FMRP is present predominantly in the cytoplasm, where it regulates translation of proteins that are important for synaptic function. We identify FMRP as a chromatin-binding protein that functions in the DNA damage response (DDR). Specifically, we show that FMRP binds chromatin through its tandem Tudor (Agenet) domain in vitro and associates with chromatin in vivo. We also demonstrate that FMRP participates in the DDR in a chromatin-binding-dependent manner. The DDR machinery is known to play important roles in developmental processes such as gametogenesis. We show that FMRP occupies meiotic chromosomes and regulates the dynamics of the DDR machinery during mouse spermatogenesis. These findings suggest that nuclear FMRP regulates genomic stability at the chromatin interface and may impact gametogenesis and some developmental aspects of fragile X syndrome.

Indexed as

SpermatogenesisAnimalsChromatinChromosome PairingDNA DamageEmbryo, MammalianFibroblastsFragile X Messenger Ribonucleoprotein 1HippocampusHistonesHumansMaleMeiosisMiceMice, KnockoutMutationChromatinFMR1 protein, humanFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1gamma-H2AX protein, mouseHistonesReceptors, AMPA

Identifiers

PMID24813610
PMCPMC4038154
OpenAlexW2091796431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.